Newsroom

Judith Ng-Cashin, chief scientific officer, Clinical Solutions discusses the surge in new medicine approvals in 2017 and what this means for the biopharmaceutical industry.

BioPharma DIVE
Ned Pagiliarulo
01.03.18

Syneos Health was created in August 2017, when INC Research and inVentiv Health merged to create the only fully-integrated biopharmaceutical solutions organization. Articles below include archived media coverage from both INC Research and inVentiv Health

Format: 2018

Select any filter and click on Apply to see results

Browse Our Archives
  • 2018 0 Articles
  • 2017 0 Articles
Topics
  • Advertising 0
  • Corporate News 0
  • Communications 0
  • Patient Recruitment 0
  • Artificial Intelligence 0
  • Commercialization 0
  • Field and Sales Teams 0
  • Real World Evidence 0
  • Regulator 0
  • Medical Science Liaisons 0
  • Regulatory 0
  • Medical Devices and Diagnostics 0
  • Pricing 0
  • Clinical Development 0
  • Millennials 0
  • Reputation and Risk Management 0
  • Predictive Analytics 0
  • Public Relations 0
  • CNS 0
  • Site and Patient Access 0
  • Market Access 0
  • Personalized Medicine 0
  • AsiaPacific 0
  • Rare Disease 0
  • Internet of Things 0
  • ICH E6 (R2) 0
  • Biosimilars 0
  • Precision Medicine 0
  • Europe 0
  • Behavioral Insights 0
  • Adherence 0
  • Influencer Communications 0
  • Healthcare Talent 0
  • Brand Naming 0
  • Medical Communications 0
  • Social Media 0
  • Study Start Up 0
  • Medical Affairs 0
  • Clinical Research Associates 0
  • Strategic Resourcing 0
Contact Our Media Relations Team Contact Our Team